Drug intelligence / Profile preview

Muscadine Plus

Development stage
Unknown
Lead developer
Sidney Kimmel Comprehensive Cancer Center
Modality
Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
Administration
Oral
01

Overview

Muscadine Plus (MPX) is a botanical dietary supplement derived from the skins and seeds of the muscadine grape (*Vitis rotundifolia*). It contains a high concentration of bioactive polyphenols, including ellagic acid, quercetin, and resveratrol. MPX is being evaluated in clinical trials, specifically for its ability to slow the doubling time of prostate-specific antigen (PSA) in men with biochemically recurrent prostate cancer following primary therapy. Research suggests that its therapeutic effect may be particularly pronounced in individuals with the Alanine/Alanine (Ala/Ala) genotype of the SOD2 gene, who may be more susceptible to oxidative stress. The supplement is thought to exert its effects through antioxidant mechanisms and the modulation of signaling pathways involved in tumor cell proliferation and inflammation.

Brand names
Muscadine Plus
Other names
Muscadine grape extractMuscadine grape skin and seed extract
02

Targets

DNAJB1 (DNAJB1 / HSP40)

Beyond the preview

Go deeper on Muscadine Plus.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Muscadine Plus.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call